(13263834), K. H., (5506013), F. X., (586649), L. X., & (2826512), Y. L. (2025). Albumin–globulin ratio is a predictive biomarker of antitumour effect of immune checkpoint inhibitors in cancer patients.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्र(13263834), Kaixiang He, Fujiang Xu (5506013), Li Xiang (586649), और Yuhao Luo (2826512). Albumin–globulin Ratio Is a Predictive Biomarker of Antitumour Effect of Immune Checkpoint Inhibitors in Cancer Patients. 2025.
एमएलए (9वां संस्करण) प्रशस्ति पत्र(13263834), Kaixiang He, et al. Albumin–globulin Ratio Is a Predictive Biomarker of Antitumour Effect of Immune Checkpoint Inhibitors in Cancer Patients. 2025.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.